Katie Johnston Takes a Bold Step as Newly Elected Member of APC Board of Directors

A New Voice in Pharmacy Advocacy

In a significant move for the healthcare landscape, Katie Johnston, a distinguished Government Affairs Associate at Revelation Pharma, has been elected to the Alliance for Pharmacy Compounding (APC) Board of Directors, representing the 4th District. This appointment marks a pivotal moment not only for her career but also for the realm of compounding pharmacy, where her insights and advocacy promise to instigate positive change.

Revelation Pharma functions as a robust network of 503A and 503B compounding pharmacies, catering to the nuanced needs of patients and prescribers across the nation. With a mission that centers on personalized medicine, Revelation Pharma's influence in the compounding community is undeniable. As someone who monitors regulations and legislation for all 50 states, Johnston's election is seen as a substantial endorsement of her capabilities and commitment to advancing the field.

In her new role, Johnston will participate actively in the governance and direction of the APC, which serves as a voice for compounding professionals nationwide, advocating for high-quality standards and access to essential medications. She expresses her enthusiasm about this position, stating: "Between growing patient needs, drug shortages, and a shift towards functional medicine, the critical role compounding plays in the healthcare space is more than apparent. I am determined to protect and represent the voices of ALL compounders."

Johnston's responsibilities at Revelation Pharma have equipped her well for this role. Frequently attending Board of Pharmacy meetings, she fosters connections with legislators while submitting valuable comments on proposed regulations. She also represents Revelation Pharma in various national coalitions, including the Federal and State Legislative and Regulatory Committees of the APC and the California Coalition.

Her election is a testament to the increasing recognition of the necessity for fresh perspectives within compounding leadership. Shawn Hodges, PharmD and CEO of Revelation Pharma, highlighted Johnston’s impact in the organization by stating, "Katie's leadership and dedication to advancing responsible compounding practices have already made a tremendous impact within Revelation Pharma. Her election to the APC Board is not only a win for our organization but for the entire compounding community. Her insight and advocacy will help drive the industry forward."

As the need for personalized medicine continues to grow, Johnston’s voice within the APC will be critical in shaping future policies and advocating for high standards in compounding pharmacy. The Alliance for Pharmacy Compounding is committed to allowing pharmacists and prescribers to work collaboratively to enhance patient care, and under Johnston's influence, the organization is set to foster innovative solutions in response to healthcare challenges.

Revelation Pharma remains dedicated to supporting and advancing the mission of compounding advocacy through strategic leadership and collaboration. With a focus on innovation and quality care, they continue to lead the way in personalizing medicine across a broad spectrum of therapeutic areas, from women’s and men’s health to pain management and dermatology.

To learn more about Revelation Pharma and its contributions to the compounding pharmacy community, visit Revelation Pharma's website. Stay connected with their updates and initiatives through platforms like Facebook, YouTube, LinkedIn, and Instagram, where they share insights and advancements within the industry.